VENTURA, Paolo
 Distribuzione geografica
Continente #
NA - Nord America 12.694
EU - Europa 11.568
AS - Asia 1.999
SA - Sud America 27
OC - Oceania 24
AF - Africa 23
Continente sconosciuto - Info sul continente non disponibili 14
Totale 26.349
Nazione #
US - Stati Uniti d'America 12.621
GB - Regno Unito 4.197
IT - Italia 4.095
SE - Svezia 974
CN - Cina 729
DE - Germania 599
UA - Ucraina 528
SG - Singapore 413
FR - Francia 370
HK - Hong Kong 313
TR - Turchia 293
FI - Finlandia 261
BG - Bulgaria 169
IN - India 89
CA - Canada 64
BE - Belgio 60
RU - Federazione Russa 49
IE - Irlanda 47
NL - Olanda 36
ID - Indonesia 35
CH - Svizzera 27
VN - Vietnam 27
MY - Malesia 25
RO - Romania 25
PL - Polonia 23
LT - Lituania 22
ES - Italia 21
IR - Iran 20
AU - Australia 18
JP - Giappone 17
BR - Brasile 14
PT - Portogallo 13
EU - Europa 12
CZ - Repubblica Ceca 11
NO - Norvegia 11
ZA - Sudafrica 9
KR - Corea 8
NZ - Nuova Zelanda 6
PH - Filippine 6
GR - Grecia 5
MX - Messico 5
HR - Croazia 4
MK - Macedonia 4
AZ - Azerbaigian 3
CL - Cile 3
EC - Ecuador 3
EG - Egitto 3
GT - Guatemala 3
HU - Ungheria 3
SM - San Marino 3
TH - Thailandia 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
AR - Argentina 2
AT - Austria 2
BO - Bolivia 2
DK - Danimarca 2
IL - Israele 2
LB - Libano 2
LK - Sri Lanka 2
MD - Moldavia 2
RE - Reunion 2
SI - Slovenia 2
ZW - Zimbabwe 2
AL - Albania 1
BN - Brunei Darussalam 1
CO - Colombia 1
CY - Cipro 1
DZ - Algeria 1
EE - Estonia 1
GH - Ghana 1
HN - Honduras 1
IQ - Iraq 1
JO - Giordania 1
LV - Lettonia 1
MA - Marocco 1
MN - Mongolia 1
NG - Nigeria 1
PE - Perù 1
QA - Qatar 1
SA - Arabia Saudita 1
SC - Seychelles 1
SD - Sudan 1
TN - Tunisia 1
VE - Venezuela 1
Totale 26.349
Città #
Southend 3.859
Fairfield 1.790
Chandler 1.194
Woodbridge 1.107
Houston 1.061
Ashburn 967
Jacksonville 814
Ann Arbor 621
Seattle 591
Wilmington 579
Dearborn 574
Cambridge 568
Nyköping 555
Singapore 323
Hong Kong 306
Rome 288
Beijing 263
Modena 219
Izmir 194
Milan 186
San Diego 186
Princeton 181
Sofia 165
Eugene 150
Helsinki 137
Bremen 89
New York 76
Des Moines 74
Rimini 64
Parma 59
Chicago 58
London 56
Palermo 56
Bologna 55
Brussels 54
Redwood City 53
Falls Church 49
Shanghai 49
Verona 49
Naples 45
Fremont 37
Florence 33
Jakarta 33
Hefei 31
Bari 29
Dublin 29
Phoenix 28
Padova 26
Toronto 26
Catania 25
Dong Ket 24
Norwalk 24
Reggio Emilia 24
San Mateo 24
Boardman 23
Turin 23
Kunming 22
Los Angeles 20
Napoli 20
Acton 18
Borzano 18
Munich 18
Nanjing 17
Torino 17
Formigine 16
Messina 16
Genoa 15
Mumbai 15
Ottawa 15
Philadelphia 15
Andover 13
Dallas 13
Kilburn 13
Amsterdam 12
Paris 12
San Giuliano Milanese 12
Brescia 11
Brno 11
Como 11
Genova 11
Guangzhou 11
Prescot 11
Augusta 10
Cagliari 10
Pisa 10
Reggio Nell'emilia 10
Trieste 10
Birmingham 9
Chiswick 9
Hounslow 9
Pescara 9
Ravenna 9
Siena 9
Trento 9
Ferrara 8
Frattamaggiore 8
Hasle-ruegsau 8
Jinan 8
Johannesburg 8
Massa Finalese 8
Totale 18.747
Nome #
Effetti dell’insulina sui livelli di omocisteina plasmatica in pazienti con diabete mellito tipo ii con e senza intolleranza alla metionina 1.875
Weight Loss Expectations in Obese Patients and Treatment Attrition: An Observational Multicenter Study 591
Validating the Body Uneasiness Test (BUT) in obese patients 531
Terapia antialadosteronica e prevenzione della cardiomiopatia cirrotica 455
Isomeri urinari della Coproporfirina in pazienti con Epatopatie Colestatiche Acquisite e sindrome di Dubin-Johnson 410
The QUOVADIS Study: features of obese Italian patients seeking treatment at specialist centers 398
Impiego dei marcatori di neoplasia (CEA, CA 19.9, CA 125, CA 16.3, NSE) in Medinina Interna: uno studio retrospettivo 395
Trombosi portale e iperomocisteinemia in pazienti con cirrosi epatica 366
EXPLORE: A Prospective, Multinational, Natural History Study of Patients with Acute Hepatic Porphyria with Recurrent Attacks 292
Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis 272
Clinical and molecular epidemiology of erythropoietic protoporphyria in Italy 261
Oxford Manuale di Medicina Clinica 251
Weight Loss Expectations in Obese Patients Seeking Treatment at Medical Centers 249
The Acute Porphyric Attack: A Difficult Diagnosis for a Potential Lethal Event in Emergency Medicine 239
Acute Intermittent Porphyria in a Child with Severe Neuropathy 234
Rhodococcus equi Pneumonia in Kidney Transplant Recipient Affected by Acute Intermittent Porphyria: A Case Report 225
Clinical impact of application of risk assessment models (Padua Prediction Score and Improve Bleeding Score) on venous thromboembolism, major hemorrhage and health expenditure associated with pharmacologic VTE prophylaxis: a “real life” prospective and retrospective observational study on patients hospitalized in a Single Internal Medicine Unit (the STIME study) 219
A challenging diagnosis for potential fatal diseases: Recommendations for diagnosing acute porphyrias 216
IS FLOW-MEDIATED DILATATION (FMD) ASSESSMENT A RELIABLE MARKER OF ENDOTHELIAL DYSFUNCTION IN LIVER CIRRHOSIS? 212
Serum and Liver Iron Differently Regulate the Bone Morphogenetic Protein 6 (BMP6)-SMAD Signaling Pathway in Mice 204
Ceruloplasmin gene variants are associated with hyperferritinemia and increased liver iron in patients with {NAFLD} 203
Weight cycling in treatment-seeking obese persons: data from the QUOVADIS study 202
Hepcidin expression does not rescue the iron-poor phenotype of Kupffer cells in Hfe-null mice after liver transplantation. 201
MARKERS OF ENDOTHELIAL DYSFUNCTION AS PREDICTORS OF ASCITIC DECOMPENSATION IN PATIENTS WITH LIVER CIRRHOSIS. 200
Safety and efficacy of sucrosomal iron in inflammatory bowel disease patients with iron deficiency anemia 198
Bone Morphogenetic Protein Signaling Is Impaired in an Hfe Knockout Mouse Model of Hemochromatosis. 195
Alendronate reduces bone resorption in HIV-associated osteopenia/osteoporosis 193
HYPERHOMOCYSTEINEMIA AND MTHFR C677T POLYMORPHISM IN PATIENTS WITH PORTAL VEIN THROMBOSIS COMPLICATING LIVER CIRRHOSIS 191
Drugs and acute porphyrias: reasons for a hazardous relationship 191
Psychological Distress in Morbid Obesity in Relation to Weight History 189
ANTIALDOSTERONE THERAPY IN LIVER CIRRHOSIS: A ROLE FOR PREVENTION OF CIRROTHIC CARDIOMIOPATHY? 184
Genetic polymorphisms of Fas (CD95) and FasL (CD178) in human longevity: studies on centenarians 184
THE INTERACTION OF BILIAR ACIDS WITH 2-HYDROXYPROPYL-CYCLODEXTRIN IN SOLUTION AND IN THE SOLID STATE 176
The Metabolic Syndrome in Treatment-Seeking Obese Persons 176
THE MOLECULAR BASIS FOR THE HEPATIC REGULATION OF HEPCIDIN, THE IRON HORMONE, BY BONE MORPHOGENETIC PROTEINS. 176
When awareness makes the difference: diagnosing and treating the acute hepatic porphyrias 174
Snoring, hypertension and Type 2 diabetes in obesity. Protection by physical activity 174
Anti- and pro-oxidant factors and endothelial dysfunction in chronic cigarette smokers with coronary heart disease 173
HIV INFECTION AND SURVIVAL IN PATIENTS WITH HCCAND LIVER CIRRHOSIS 171
Antiviral treatment profoundly affects iron status in HCV patients: Implications for management and treatment outcome 170
Platelet count does not predict bleeding in cirrhotic patients: Results from the PRO-LIVER Study 170
A role for homocysteine increase in haemolysis of megaloblastic anaemias due to vitamin B-12 and folate deficiency: results from an in vitro experience 168
Studi preformulativi sul complesso di inclusione tra acido ursodesossicolico e beta-ciclodestrine 168
A large deletion on chromosome 11 in acute intermittent porphyria 167
The Effect of Obesity Management on Body Image in Patients Seeking Treatment at Medical Centers 167
Pathological fractures in AIDS patients with osteopenia and osteoporosis induced by antiretroviral therapy 165
Hyperhomocysteinaemia in chronic liver diseases: role of disease stage, vitamin status and methylenetetrahydrofolate reductase genetics 163
Molecular characterization, by digital PCR analysis of four HMBS gene mutations affecting the ubiquitous isoform of Porphobilinogen Deaminase (PBGD) in patients with Acute Intermittent Porphyria (AIP) 163
Red wine consumption prevents vascular oxidative stress induced by a high-fat meal in healthy volunteers 162
Serum ferritin as a predictor of treatment outcome in patients with chronic hepatitis C 162
Prevention of a first episode of variceal bleeding: role of duplex Doppler sonographic measurement of the acute response to beta-blockers. 161
Hepatocellular Carcinoma in HIV-infected Patients: Check Ealy, Treat Hard 161
Construct Validity of the Short Form-36 Health Survey and Its Relationship with BMI in Obese Outpatients 161
Tumour markers in internal medicine: a low-cost test or an unnecessary expense? A retrospective study based on appropriateness 161
Alendronate treatment for osteoporosis in patients infected with human immunodeficiency virus. 157
Hyperhomocysteinaemia in HIV-infected patients: determinants of variability and correlations with predictors of cardiovascular disease. 156
N-acetyl-cysteine reduces homocysteine plasma levels after single intravenous administration by increasing thiols urinary excretion 154
Clinical and psychological correlates of health related quality of life in obese patients 153
Portal vein thrombosis relevance on liver cirrhosis: Italina Venous Thrombotic Events Registry 153
Parametri predittivi e risposta sostenuta alla terapia antivirale combinata nell'epatite cronica attivva HCV correlata (ECA HCV) 153
Pro-oxidant and antioxidant factors in acute intermittent porphyria: Family studies 153
Impact of nutrition on cognition and affectivity in the elderly: A review 150
Weight management, psychological distress and binge eating in obesity. A reappraisal of the problem 150
Role of Multidrug-Resistance Protein 2 in coproporphyrin transport: results from experimental studies in bile fistula rat models 149
Antialdosterone therapy in liver cirrhosis: a role for prevention of cirrhitc cardiomiopathy ? 148
Porfiria acuta intermittente: un caso "eccezionale" 148
EXPLORE: A prospective, multinational natural history study of acute hepatic porphyria patients with recurrent attacks 148
Relevance of different apolipoprotein content in binding of homocysteine to plasma lipoproteins 146
Weight loss and clinical characteristics of young adults patients seeking treatment at medical centers: Data from the QUOVADIS Study 146
Prevalence Of Subclinical Liver Fibrosis Among Patients With Idiopathic Pulmonary Fibrosis 144
Personality features of obese women in relation to binge eating and night eating 142
Metabolic syndrome, psychological status and quality of life in obesity: the QUOVADIS Study 141
Hepatocellular carcinoma in HIV infected patients: check early, treat hard. 141
MTHFR C677T polymorhism and hyperhomocysteinemia in patients with liver cirrhosis complicated by portal vein thrombosis and hepatocellular carcinoma 140
Hyperhomocysteinemia and related factors in 600 hospitalized elderly subjects 139
Clinical, biochemical and genetic characteristics of Variegate Porphyria in Italy 138
Radiofrequency ablation combined with transcatheter arterial chemioembolization in the treatment of advanced hepatocellular carcinoma 138
CLINICAL OUTCOMES AND SURVIVAL IN PATIENTS WITH HEPATOCELLULAR CARCINOMA AND HIV INFECTION 138
Peroxidation indices and total antioxidant capacity in plasma during hyperhomocysteinemia induced by methionine oral loading 137
Does the measurement of portal flow velocity have any value in the identification of patients with cirrhosis at risk of digestive bleeding ? 136
Alendronate reduces bone turnover in HIV-associated Osteopenia and Osteoporosis 135
Affinità dell'omocisteina per le lipoproteine 133
Interindividual variability of the number connection test 131
Serum endothelin-1 as predictor of ascitic decompensation in patients with liver cirrhosis 131
Novel human pathological mutations. Gene symbol: PPOX. Disease: porphyria, variegate 130
Urinary coproporhyrin isomers during therapy with IFn-RIBA in patients with chronic hepatitis due to HCV infection 129
Distribution of homocysteine in plasma lipoproteins 129
Correlation between plasma malonyldialdeide levels and paroxonase activity in healthy subjects and in patients with atherosclerotic disease 128
Hyperhomocysteinemia and other newly recognized inherited coagulation disorders (factor V Leiden and prothrombin gene mutation) in patients with idiopathic cerebral vein thrombosis 128
Duplex-Doppler ultrasonography in the evaluation of cirrhotic patients with portal hypertension and in the analysis of their response to drugs 128
Hyperhomocysteinemia in patients with acute porphyrias: A potentially dangerous metabolic crossroad? 128
Duplex-Doppler assessment of cirrhosis in patients with chronic compensated liver disease 127
Insulin resistance in advanced liver cirrhosis : the role of liver dysfunction and the “dissociated” effect on glucose versus lipid and amino acid metabolism 126
One- and two-dimensional NMR study of complexation of ursodeoxycholic acid with beta-cyclodextrin 125
Sarcoma primitivo del cuore. Descrizione di un caso 125
Improvement of survival in patients with intermediate stage (BCLC-B) hepatocellular acrcinoma complicating liver cirrhosis by combination therapy with radiofrequency ablation and transcatheter chemioembolization 125
Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: results from the SIMI-COVID-19 study of the Italian Society of Internal Medicine (SIMI) 124
Efficacy and safety of combination therapy with pegylated interferon and ribavirin in aged patients with chronic hepatitis C 123
Homocysteine Production and membrane oxidative stress in erythrocytes 120
Ursodeoxycholic acid complexation with 2-hydroxypropyl-beta-cyclodextrin increases ursodeoxycholic acid biliary excretion after single oral administration in rats 120
Totale 20.258
Categoria #
all - tutte 97.376
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 97.376


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.804 0 0 0 449 579 831 1.023 437 541 316 335 293
2020/20215.014 355 277 422 406 646 404 652 458 289 459 347 299
2021/20223.669 178 412 290 308 143 217 211 219 407 316 538 430
2022/20234.119 423 420 318 370 452 551 118 389 491 112 229 246
2023/20242.739 168 179 241 227 399 196 225 336 115 124 192 337
2024/2025901 322 149 325 105 0 0 0 0 0 0 0 0
Totale 26.610